India to Mexico: Insulin Export Trade Route

The India to Mexico Insulin corridor is one of India's established pharmaceutical export routes, with 37 shipments documented worth a combined $14.6M USD. The route is dominated by WOCKHARDT LIMITED , which alone accounts for roughly 52% of all export value, reflecting the consolidated nature of India's insulin manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $395.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with insulin's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 23.4%, placing it at rank #11 among India's top insulin export destinations globally.

On the import side, key buyers of Indian insulin in Mexico include AYUSH PHARMA S.A DE C.V. , AYUSH PHARMA S A DE C V, INNODRIVE GROUP S.A DE CV and 3 others. AYUSH PHARMA S.A DE C.V. is the single largest importer with 12 shipments valued at $7.7M USD.

India's insulin exports to Mexico are driven primarily by a handful of large-scale manufacturers. WOCKHARDT LIMITED with 12 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Mexico benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — WOCKHARDT LIMITED , WOCKHARDT LIMITED, ORBIT LIFESCIENCE PVT. LTD. — together account for 93% of total trade value on this route. The average shipment value of $395.5K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as valvey 100iu ml 10ml vial insulin glargine solution 100 iu ml and valvey 100iu/ml 10ml vial (insulin glargine solution 100 iu/ml)vls, suggesting that buyers in Mexico tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, AYUSH PHARMA S.A DE C.V. is the largest importer with 12 shipments worth $7.7M USD — representing 52% of all insulin imports from India on this route. A total of 6 buyers are active on this corridor.